Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer

Autor: Markus Rechsteiner, Beatriz Bellosillo, Linea Cecilie Melchior, Linda Lind, Ernest Nadal, Nicol Trincheri, Mitja Rot, Estelle Taranchon-Clermont, E. J. Speel, Guido M.J.M. Roemen, Sebastian Dintner, Christina Frykman, Yun-Chung Nam-Apostolopoulos, Mary Jones, Emma Andrew, Mar Varela-Rodriguez, Sandra N. Freiberger, Izidor Kern, Jennifer Ridgway, Isabelle Rouquette, Samuel Murray, Solène M. Evrard, Klaus H. Wiedorn

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Molecular Diagnostics, 21(6), 1010-1024. Elsevier Science
Journal of Molecular Diagnostics
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2019, 21, pp.1010-1024. ⟨10.1016/j.jmoldx.2019.06.010⟩

Before initiating treatment of advanced non-small-cell lung cancer with tyrosine kinase inhibitors (eg, erlotinib, gefitinib, osimertinib, and afatinib), which inhibit the catalytic activity of epidermal growth factor receptor (EGFR), clinical guidel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42334e133c382caa8138db24cf398906
https://cris.maastrichtuniversity.nl/en/publications/7a35cb16-9c32-4222-af99-4f1cc8e84012

The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures

Autor: Teresa Soler, Catalina Falo, María Jesús Pla, Mar Varela-Rodriguez, Amparo Garcia-Tejedor, Cecilia Quetglas, Jordi Ponce, Sonia Pernas, Maria Eulalia Fernandez Montoli, Sergi Fernandez-Gonzalez, Maite Bajen, Miriam Campos, Xavier Perez-Martin, Raul Ortega

Publikováno v: CLIN BREAST CANCER
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu

BACKGROUND: In patients with breast cancer who are candidates for neoadjuvant therapy (NAT), the timing of when to perform sentinel lymph node biopsy (SLNB) remains under discussion. The aim of this study was to compare the advantages and disadvantag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e58b6ac88ab5ad13a8bbfced9b9e2f
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13380